Peringatan Keamanan

Please refer to DB01049 and to know more about the isomer please refer to DB11274.

Epicriptine

DB11275

small molecule approved

Deskripsi

Epicriptine is also known as beta-dihydroergocryptine presents a molecular formula of 9,10 alpha-dihydro-13'-epi-b-ergocryptine. Together with the alpha-dihydroergocryptine, it represents one-third of the ergoloid mesylate mixture. Epicriptine differs from the alpha form on the position of one methyl group.T195 To know more about the mixture please visit DB01049

Struktur Molekul 2D

Berat 577.726
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Volume Distribusi Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].
Klirens (Clearance) Please refer to [DB01049] and to know more about the isomer please refer to [DB11274].

Absorpsi

Please refer to DB01049 and to know more about the isomer please refer to DB11274.

Metabolisme

Please refer to DB01049 and to know more about the isomer please refer to DB11274.

Rute Eliminasi

Please refer to DB01049 and to know more about the isomer please refer to DB11274.

Interaksi Obat

93 Data
Cabergoline The risk or severity of adverse effects can be decreased when Cabergoline is combined with Epicriptine.
Ropinirole The risk or severity of adverse effects can be decreased when Ropinirole is combined with Epicriptine.
Dihydroergotamine The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Epicriptine.
Pramipexole The risk or severity of adverse effects can be decreased when Pramipexole is combined with Epicriptine.
Lisuride The risk or severity of adverse effects can be decreased when Lisuride is combined with Epicriptine.
Apomorphine The risk or severity of adverse effects can be decreased when Apomorphine is combined with Epicriptine.
Fenoldopam The risk or severity of adverse effects can be decreased when Fenoldopam is combined with Epicriptine.
Ergoloid mesylate The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Epicriptine.
Pergolide The risk or severity of adverse effects can be decreased when Pergolide is combined with Epicriptine.
Bromocriptine The risk or severity of adverse effects can be decreased when Bromocriptine is combined with Epicriptine.
Aripiprazole The risk or severity of adverse effects can be decreased when Aripiprazole is combined with Epicriptine.
Rotigotine The risk or severity of adverse effects can be decreased when Rotigotine is combined with Epicriptine.
Quinagolide The risk or severity of adverse effects can be decreased when Quinagolide is combined with Epicriptine.
Brexpiprazole The risk or severity of adverse effects can be decreased when Brexpiprazole is combined with Epicriptine.
Dopexamine The risk or severity of adverse effects can be decreased when Epicriptine is combined with Dopexamine.
Piribedil The risk or severity of adverse effects can be decreased when Epicriptine is combined with Piribedil.
Dihydrexidine The risk or severity of adverse effects can be decreased when Epicriptine is combined with Dihydrexidine.
Dihydroergocryptine The risk or severity of adverse effects can be decreased when Epicriptine is combined with Dihydroergocryptine.
Metergoline The risk or severity of adverse effects can be decreased when Epicriptine is combined with Metergoline.
Ziprasidone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Ziprasidone.
Olanzapine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Olanzapine.
Methylergometrine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Methylergometrine.
Clozapine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Clozapine.
Thiethylperazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Thiethylperazine.
Sulpiride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Sulpiride.
Loxapine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Loxapine.
Remoxipride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Remoxipride.
Promazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Promazine.
Prochlorperazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Prochlorperazine.
Droperidol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Droperidol.
Chlorpromazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Chlorpromazine.
Buspirone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Buspirone.
Haloperidol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Haloperidol.
Triflupromazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Triflupromazine.
Amoxapine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Amoxapine.
Fluphenazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Fluphenazine.
Thioridazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Thioridazine.
Risperidone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Risperidone.
Propiomazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Propiomazine.
Trifluoperazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Trifluoperazine.
Perphenazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Perphenazine.
Flupentixol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Flupentixol.
Mesoridazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Mesoridazine.
Carphenazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Carphenazine.
Acetophenazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Acetophenazine.
Promethazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Promethazine.
Pimozide The therapeutic efficacy of Epicriptine can be decreased when used in combination with Pimozide.
Domperidone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Domperidone.
Quetiapine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Quetiapine.
Metoclopramide The therapeutic efficacy of Epicriptine can be decreased when used in combination with Metoclopramide.
Chlorprothixene The therapeutic efficacy of Epicriptine can be decreased when used in combination with Chlorprothixene.
Paliperidone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Paliperidone.
Yohimbine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Yohimbine.
Methotrimeprazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Methotrimeprazine.
Alizapride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Alizapride.
Periciazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Periciazine.
Acepromazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Acepromazine.
Aceprometazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Aceprometazine.
Molindone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Molindone.
Pipotiazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Pipotiazine.
Thioproperazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Thioproperazine.
Thiothixene The therapeutic efficacy of Epicriptine can be decreased when used in combination with Thiothixene.
Zuclopenthixol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Zuclopenthixol.
Fluspirilene The therapeutic efficacy of Epicriptine can be decreased when used in combination with Fluspirilene.
Iloperidone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Iloperidone.
Lumateperone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Lumateperone.
YKP-1358 The therapeutic efficacy of Epicriptine can be decreased when used in combination with YKP-1358.
Sertindole The therapeutic efficacy of Epicriptine can be decreased when used in combination with Sertindole.
Asenapine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Asenapine.
Amisulpride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Amisulpride.
Lurasidone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Lurasidone.
Perospirone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Perospirone.
Bromopride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Bromopride.
AS-8112 The therapeutic efficacy of Epicriptine can be decreased when used in combination with AS-8112.
Blonanserin The therapeutic efficacy of Epicriptine can be decreased when used in combination with Blonanserin.
Melperone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Melperone.
Zotepine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Zotepine.
Pipamperone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Pipamperone.
Azaperone The therapeutic efficacy of Epicriptine can be decreased when used in combination with Azaperone.
Tetrahydropalmatine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Tetrahydropalmatine.
Ecopipam The therapeutic efficacy of Epicriptine can be decreased when used in combination with Ecopipam.
Raclopride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Raclopride.
JNJ-37822681 The therapeutic efficacy of Epicriptine can be decreased when used in combination with JNJ-37822681.
Perazine The therapeutic efficacy of Epicriptine can be decreased when used in combination with Perazine.
Benperidol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Benperidol.
Tiapride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Tiapride.
Sultopride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Sultopride.
Clebopride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Clebopride.
Trifluperidol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Trifluperidol.
Penfluridol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Penfluridol.
Clopenthixol The therapeutic efficacy of Epicriptine can be decreased when used in combination with Clopenthixol.
Fallypride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Fallypride.
Eticlopride The therapeutic efficacy of Epicriptine can be decreased when used in combination with Eticlopride.

Target Protein

Dopamine receptor DRD1

Referensi & Sumber

Textbook
  • ISBN: 3-7692-3483-9
    Steinhilber, D., Schubert M. and Roth H. (2005). Medizinische Chemie. Deutscher Apotheker Verlag.

Contoh Produk & Brand

Produk: 5 • International brands: 0
Produk
  • Ergoloid Mesylates
    Tablet • - • Oral • US • Generic • Approved
  • Ergoloid Mesylates
    Tablet • - • Oral • US • Generic • Approved
  • Ergoloid Mesylates
    Tablet • - • Oral • US • Generic • Approved
  • Ergoloid Mesylates
    Tablet • - • Oral • US • Generic • Approved
  • Ergoloid Mesylates
    Tablet • - • Oral • US • Generic • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul